Baloxavir Marboxil Xofluza Antiviral
UK HEALTH AND SECURITY AGENCYcontractFind a Tender ↗Ref ocds-h6vhtk-05ac7eProcurement Act 2023pending
Estimated value
—
Awarded value
£1
Awarded 29 Sept 2025
Suppliers
1
Lots
1
1 awarded
Published
10 Oct 2025
Description
The UK Health Security Agency wishes to establish a contract with a supplier for the supply of Baloxavir Marboxil Xofluza Antiviral
Scope
- Reference
- C338791
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£1
Award date
29 Sept 2025
Contract start
01 Nov 2025
Contract end
01 Nov 2026
Awarded to
RP
CH 00100674
Awarded suppliers· 1 supplier
Awarded 29 Sept 2025 · Contract period 01 Nov 2025 — 01 Nov 2026
Award value
£1
Other contracts from UK HEALTH AND SECURITY AGENCY
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to ROCHE PRODUCTS LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| Transitional Drugs 7 | contract | — | 05 Jun 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NP90425 Faricimab (Vabysmo®) | contract | — | 11 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NHS National Framework for the supply of Tocilizumab Injection | contract | — | 30 Dec 2025 |
| NHS National Framework for the supply of Tocilizumab Injection | contract | — | 27 Nov 2025 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | contract | — | 01 Aug 2025 |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | contract | £47.0m | 29 Jul 2025 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | contract | £9.4m | 24 Jul 2025 |